CYCCP

Q: What is the price of Cyclacel Pharmaceuticals (CYCCP) today?

The current price of Cyclacel Pharmaceuticals (CYCCP) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Cyclacel Pharmaceuticals (CYCCP) pay dividends?

Cyclacel Pharmaceuticals (CYCCP) did not pay dividends over the past year.

Cyclacel Pharmaceuticals Inc.

Price

$ -

return (12m)

0.00%

p/e

-8.63

p/bv

3.14

DIVIDEND YIELD

33.29%

CYCCP price

CYCCP

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CYCCP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CYCCP

review the fundamentals of Cyclacel Pharmaceuticals shares

P/E

-8.63

Sector: -3.96 Industry: -3.96

P/S (PSR)

Sector: -3.88 Industry: -3.88

P/BV

3.14

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

33.29%

Sector: - Industry: -

ROA

-30.00%

Sector: -61.39% Industry: -61.39%

ROE

-36.36%

Sector: -60.71% Industry: -60.71%

ROIC

Sector: -1,194.93% Industry: -1,194.93%

NET MARGIN

0.00%

Sector: -39.39% Industry: -39.39%

GROSS MARGIN

0.00%

Sector: 38.09% Industry: 38.09%

OPERATING MARGIN

0.00%

Sector: -39.58% Industry: -39.58%

EV/EBITDA

-8.63

Sector: -3.80 Industry: -3.80

EV/EBIT

-8.63

Sector: -4.02 Industry: -4.02

PRICE-TO-ASSETS

2.59

Sector: 1.38 Industry: 1.38

BVPS

2.30

Sector: 1.89 Industry: 1.89

EPS

-0.84

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.83

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.18

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals CYCCP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.88	7.40	33.81%	2.14%	$ 586.59 B	28.46%
PFE	20.06	1.67	8.35%	6.28%	$ 155.85 B	12.42%
ABBV	89.02	0.00	0.00%	3.12%	$ 376.19 B	6.91%
NVO	10.61	5.46	51.50%	4.98%	$ 166.18 B	33.05%
MRK	16.72	0.00	0.00%	2.70%	$ 305.21 B	28.08%
AZN	31.27	6.56	20.99%	1.55%	$ 319.77 B	17.41%
GILD	20.77	7.81	37.62%	2.24%	$ 176.72 B	28.90%
BMY	16.98	-3.52	-20.72%	4.23%	$ 119.74 B	14.64%
ZTS	19.59	15.72	80.25%	1.70%	$ 52.37 B	28.23%
REGN	17.51	2.52	14.41%	0.47%	$ 78.86 B	31.41%
HALO	24.94	161.91	649.21%	0.00%	$ 7.90 B	22.69%
AMGN	24.97	22.24	89.06%	2.70%	$ 192.51 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.42	6.02	21.18%	0.00%	$ 112.36 B	32.94%
CAH	30.78	-18.95	-61.56%	0.94%	$ 51.16 B	0.68%
HRMY	10.31	1.88	18.24%	0.00%	$ 1.64 B	18.27%
ADMA	16.29	5.01	30.78%	0.00%	$ 2.39 B	28.80%
BIIB	20.21	1.43	7.08%	0.00%	$ 26.12 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CYCCP Historical Dividends

current DY: 33.29%

5-year average DY: 843.84%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	10/20/2025	11/01/2025	0,15000000
Dividends	07/21/2025	08/01/2025	0,15000000
Dividends	04/29/2025	05/01/2025	2,25000000
Dividends	01/22/2024	02/01/2024	2,25000000
Dividends	10/20/2023	11/01/2023	2,25000000
Dividends	07/21/2023	08/01/2023	2,25000000
Dividends	04/21/2023	05/01/2023	2,25000000
Dividends	01/13/2023	02/01/2023	2,25000000
Dividends	10/14/2022	11/01/2022	2,25000000
Dividends	07/15/2022	08/01/2022	2,25000000
Dividends	04/14/2022	05/01/2022	2,25000000
Dividends	01/14/2022	02/01/2022	2,25000000
Dividends	10/15/2021	11/01/2021	2,25000000
Dividends	07/16/2021	08/01/2021	2,25000000
Dividends	04/16/2021	05/01/2021	2,25000000
Dividends	01/15/2021	02/01/2021	2,25000000
Dividends	10/16/2020	11/01/2020	2,25000000
Dividends	07/17/2020	08/01/2020	2,25000000
Dividends	04/15/2020	05/01/2020	2,25000000
Dividends	01/17/2020	02/01/2020	2,25000000
Dividends	10/14/2019	11/01/2019	2,25000000
Dividends	07/12/2019	08/01/2019	2,25000000
Dividends	04/15/2019	05/01/2019	2,25000000
Dividends	01/14/2019	02/01/2019	2,25000000
Dividends	10/15/2018	11/01/2018	2,25000000
Dividends	07/13/2018	08/01/2018	2,25000000
Dividends	04/11/2018	05/01/2018	2,25000000
Dividends	01/12/2018	02/01/2018	2,25000000
Dividends	10/13/2017	11/01/2017	2,25000000
Dividends	07/14/2017	08/01/2017	2,25000000
Dividends	04/14/2017	05/01/2017	2,25000000
Dividends	01/18/2017	02/01/2017	2,25000000
Dividends	10/17/2016	11/01/2016	2,25000000
Dividends	07/15/2016	08/01/2016	2,25000000
Dividends	04/18/2016	05/01/2016	2,25000000
Dividends	01/21/2016	02/01/2016	2,25000000
Dividends	10/23/2015	11/02/2015	2,25000000
Dividends	07/17/2015	08/03/2015	2,25000000
Dividends	04/17/2015	05/01/2015	2,25000000
Dividends	01/05/2015	02/02/2015	2,25000000
Dividends	10/01/2014	11/01/2014	2,25000000
Dividends	07/01/2014	08/01/2014	2,25000000
Dividends	04/18/2014	05/01/2014	2,25000000
Dividends	01/17/2014	02/03/2014	2,25000000
Dividends	10/21/2013	11/01/2013	2,25000000
Dividends	07/22/2013	08/01/2013	2,25000000
Dividends	04/19/2013	05/01/2013	2,25000000
Dividends	01/22/2013	02/01/2013	2,25000000
Dividends	04/22/2011	05/02/2011	2,25000000
Dividends	01/21/2011	02/01/2011	2,25000000
Dividends	01/19/2009	01/30/2009	2,25000000
Dividends	10/20/2008	11/01/2008	2,25000000
Dividends	07/18/2008	08/01/2008	2,25000000
Dividends	04/18/2008	05/01/2008	2,25000000
Dividends	01/18/2008	02/01/2008	2,25000000
Dividends	10/19/2007	11/01/2007	2,25000000
Dividends	07/20/2007	08/01/2007	2,25000000
Dividends	04/20/2007	05/01/2007	2,25000000
Dividends	01/22/2007	02/01/2007	2,25000000
Dividends	10/23/2006	11/01/2006	2,25000000
Dividends	07/24/2006	08/01/2006	2,25000000
Dividends	04/29/2006	05/01/2006	2,25000000
Dividends	01/20/2006	02/01/2006	2,25000000
Dividends	10/21/2005	11/01/2005	2,25000000
Dividends	07/22/2005	08/01/2005	2,25000000
Dividends	04/22/2005	05/02/2005	2,25000000
Dividends	01/21/2005	02/01/2005	2,19600000

ABOUT Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

29 years

Founded: 1997

2006

Time since IPO - 20 years

12

Employees

Cyclacel Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $11.39 Millions, with shareholders equity totaling $3.63 Millions.

The company employs approximately 12 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Cyclacel Pharmaceuticals Inc. reported $- in revenue, generating net income of $-1.32 Million.

Key financial metrics include a P/E ratio of -8.63, a price-to-book (P/B) ratio of 3.14, and a trailing twelve-month dividend yield of 33.29%.

The company trades under the ticker CYCCP.

Market cap

$ 11.39 Millions

Net worth

$ 3.63 Millions

$ 3,630,000.00

Assets

$ 4.40 Millions

$ 4,400,000.00

Total Shares Outstanding

1.58 Million

1,580,000

Average Daily Trading Volume

$ 7.47 Thousand

$ 7,474.58

Sector

Health Care

Industry

Biotechnology

CYCCP

CYCCP revenue and profits

Financial Results CYCCP

DRAG THE FRAME TO SEE MORE DATA

CYCCP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 866.38 24,78% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 213.99 60,64% (12M)

P/E

30.78

0.94%

ROE

-61.56%

P/BV

-18.95

JNJ - Johnson & Johnson

$ 234.18 52,86% (12M)

P/E

21.88

2.14%

ROE

33.81%

P/BV

7.40

PFE - Pfizer

$ 27.56 33,52% (12M)

P/E

20.06

6.28%

ROE

8.35%

P/BV

1.67

ABBV - AbbVie

$ 208.38 25,43% (12M)

P/E

89.02

3.12%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 119.07 58,20% (12M)

P/E

16.72

2.70%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 204.80 55,80% (12M)

P/E

31.27

1.55%

ROE

20.99%

P/BV

6.56

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 866.38 24,78% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 213.99 60,64% (12 M)

P/L

30.78

0.94%

ROE

-61.56%

P/VP

-18.95

JNJ - Johnson & Johnson

$ 234.18 52,86% (12 M)

P/L

21.88

2.14%

ROE

33.81%

P/VP

7.40

PFE - Pfizer

$ 27.56 33,52% (12 M)

P/L

20.06

6.28%

ROE

8.35%

P/VP

1.67

ABBV - AbbVie

$ 208.38 25,43% (12 M)

P/L

89.02

3.12%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 119.07 58,20% (12 M)

P/L

16.72

2.70%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 204.80 55,80% (12 M)

P/L

31.27

1.55%

ROE

20.99%

P/VP

6.56

Frequently Asked Questions

What is the price of Cyclacel Pharmaceuticals (CYCCP) today?

The current price of Cyclacel Pharmaceuticals (CYCCP) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Cyclacel Pharmaceuticals (CYCCP) pay dividends?

Cyclacel Pharmaceuticals (CYCCP) did not pay dividends over the past year.

Is Cyclacel Pharmaceuticals (CYCCP) a good investment?

Cyclacel Pharmaceuticals (CYCCP) is currently trading at $ 0.00 with a P/E ratio of -8.63%. This represents a -863% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 33.29%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Cyclacel Pharmaceuticals (CYCCP) stock?

You can buy Cyclacel Pharmaceuticals (CYCCP) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CYCCP and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Cyclacel Pharmaceuticals (CYCCP) yield today?

Over the past month, Cyclacel Pharmaceuticals (CYCCP) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.45 per share in dividends, resulting in a dividend yield of 33.29%.

If you were to purchase 100 shares of Cyclacel Pharmaceuticals (CYCCP) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CYCCP

Cyclacel Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CYCCP

review the fundamentals of Cyclacel Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 33.29%

5-year average DY: 843.84%

type

Ex - Dividend Date

payment date

value

ABOUT Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

United States

29 years

2006

12

Financial Results CYCCP

CYCCP cash flow

Asset, Revenue and Profit Growth - CYCCP

CYCCP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions